Vertex Pharmaceuticals Incorporated
VRTX
$434.96
-$2.06-0.47%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.29B | 6.38B | 6.20B | 6.12B | 6.52B |
| Total Receivables | 1.95B | 1.89B | 1.81B | 1.61B | 1.75B |
| Inventory | 1.63B | 1.50B | 1.36B | 1.21B | 1.08B |
| Prepaid Expenses | 694.50M | 639.90M | 581.60M | 459.20M | 438.70M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 14.90M | 12.40M | 61.20M | 206.50M | 10.50M |
| Total Current Assets | 10.57B | 10.43B | 10.01B | 9.60B | 9.80B |
|
|
|||||
| Total Current Assets | 10.57B | 10.43B | 10.01B | 9.60B | 9.80B |
| Net Property, Plant & Equipment | 3.02B | 2.65B | 2.63B | 2.58B | 2.51B |
| Long-term Investments | 1.09B | 1.09B | 1.09B | 1.09B | 1.09B |
| Goodwill | 1.09B | 1.09B | 1.09B | 1.09B | 1.09B |
| Total Other Intangibles | 429.80M | 435.50M | 441.20M | 825.90M | 831.60M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.95B | 3.72B | 3.49B | 3.27B | 3.23B |
| Total Assets | 24.86B | 24.04B | 22.88B | 22.53B | 22.24B |
|
|
|||||
| Total Accounts Payable | 420.30M | 442.30M | 445.00M | 413.00M | 395.80M |
| Total Accrued Expenses | 3.61B | 3.27B | 2.95B | 2.63B | 3.22B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | 92.30M | 71.20M |
| Total Finance Division Other Current Liabilities | 441.50M | 425.40M | 386.40M | 431.80M | 286.40M |
| Total Other Current Liabilities | 441.50M | 425.40M | 386.40M | 431.80M | 286.40M |
| Total Current Liabilities | 4.48B | 4.14B | 3.78B | 3.56B | 3.97B |
|
|
|||||
| Total Current Liabilities | 4.48B | 4.14B | 3.78B | 3.56B | 3.97B |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.83B | 1.53B | 1.65B | 1.66B | 1.70B |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.23B | 1.20B | 951.90M | 901.80M | 933.30M |
| Total Liabilities | 7.54B | 6.86B | 6.38B | 6.12B | 6.61B |
|
|
|||||
| Common Stock & APIC | 5.01B | 5.99B | 6.18B | 6.68B | 6.91B |
| Retained Earnings | 12.37B | 11.29B | 10.25B | 9.61B | 8.69B |
| Treasury Stock & Other | -64.50M | -101.10M | 68.10M | 127.80M | 28.80M |
| Total Common Equity | 17.32B | 17.18B | 16.50B | 16.41B | 15.63B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 17.32B | 17.18B | 16.50B | 16.41B | 15.63B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 17.32B | 17.18B | 16.50B | 16.41B | 15.63B |
|
|
|||||